I see value.
Hylid propose a stand-alone sensor that when used with Archer’s biochip will meet potassium measurement accuracy requirements. The market for remote care capability is massive, many many billions. Testing will largely come down to repeatabilty and accuracy, smarter people than me see this as doable.
I bought a small amount this week to round off my recent buys in what I think is a special risk/reward given its potential pathway to money.
Cheers
Phil.
I see value.Hylid propose a stand-alone sensor that when used...
Add to My Watchlist
What is My Watchlist?
 (20min delay)
|
|||||
|
Last
27.0¢ |
Change
-0.010(3.57%) |
Mkt cap ! $68.80M | |||
| Open | High | Low | Value | Volume |
| 28.0¢ | 28.0¢ | 27.0¢ | $9.488K | 35.01K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 11424 | 27.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 27.5¢ | 67228 | 2 |
View Market Depth
| Last trade - 15.59pm 16/06/2025 (20 minute delay) ? |
| AXE (ASX) Chart |